Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05914883

The NORwegian Atrial Fibrillation Self-SCREENing

Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oslo Unvirsity Hospital

Oslo, Norway

About this study

This randomized clinical trial will evaluate whether self-screening for AF with the ECG247 patch monitor will reduce AF-related morbidity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥65 years and minimum one other risk factor for stroke according to the CHA2DS2-VASc risk score: Age ≥75 years, Diabetes, Heart failure, Hypertension, Previous stroke/TIA and/or Vascular disease
  • Informed consent for participation

Exclusion criteria

  • History of AF (self-reported)
  • Use of anticoagulation therapy
  • Pacemaker/CRT device
  • No smart phone

Treatment and study plan

Long-term continuous ECG monitoring

Diagnostic Test

Long-term continuous ECG monitoring with ECG247 Smart Heart Sensor

Primary outcomes

  1. Stroke

    Time frame: 5 years

    percent per year

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Haukeland University Hospital
  • Sorlandet Hospital HF
  • St. Olavs Hospital
  • University Hospital of North Norway

Registry information

Acronym: NORSCREEN

Important dates

Study start
2023
Primary completion
2029
Study completion
2029
First posted
Jun 22, 2023
Registry last updated
Jul 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.